- Report
- March 2026
- 336 Pages
Canada
From €4305EUR$4,850USD£3,730GBP
- Report
- January 2024
- 150 Pages
Global
From €4305EUR$4,850USD£3,730GBP
- Report
- October 2023
- 150 Pages
Global
From €4305EUR$4,850USD£3,730GBP
- Report
- August 2023
- 150 Pages
Global
From €4305EUR$4,850USD£3,730GBP
From €4305EUR$4,850USD£3,730GBP
- Report
- January 2025
- 62 Pages
Portugal
From €1771EUR$1,995USD£1,535GBP
- Training
- 60 Minutes
Global
- Report
- November 2025
- 107 Pages
Global
From €3500EUR$4,223USD£3,139GBP
- Report
- October 2024
- 81 Pages
Global
From €3500EUR$4,223USD£3,139GBP
- Report
- July 2024
- 97 Pages
Global
From €3500EUR$4,223USD£3,139GBP
- Report
- February 2024
- 103 Pages
Global
From €3500EUR$4,223USD£3,139GBP
- Report
- July 2023
- 81 Pages
Global
From €3500EUR$4,223USD£3,139GBP
- Report
- November 2025
- 132 Pages
Global
From €843EUR$950USD£731GBP
- Report
- November 2025
- 132 Pages
Global
From €843EUR$950USD£731GBP
- Report
- January 2025
- 132 Pages
Global
From €843EUR$950USD£731GBP
- Report
- January 2025
- 132 Pages
Global
From €843EUR$950USD£731GBP
- Report
- January 2025
- 132 Pages
Global
From €843EUR$950USD£731GBP
- Report
- November 2021
- 1112 Pages
Global
From €5326EUR$6,000USD£4,615GBP

The Digital Polymerase Chain Reaction (dPCR) market is a subset of the genomics industry. It is a technology used to detect and quantify nucleic acid molecules, such as DNA and RNA. It is a highly sensitive and specific method for detecting and quantifying nucleic acid molecules, and is used in a variety of applications, including gene expression analysis, genotyping, and diagnostics. dPCR is also used in research and development, as well as in clinical settings.
dPCR is a cost-effective and efficient method for detecting and quantifying nucleic acid molecules, and is becoming increasingly popular in the genomics industry. It is used in a variety of applications, including gene expression analysis, genotyping, and diagnostics.
Some companies in the dPCR market include Bio-Rad, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Illumina. Show Less Read more